Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer (RISAROS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00859703
Recruitment Status : Completed
First Posted : March 11, 2009
Last Update Posted : October 31, 2013
Information provided by (Responsible Party):
Hospices Civils de Lyon

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2013
  Study Completion Date : October 2013